N-Ethyltryptamine


N-Ethyltryptamine, also abbreviated as NETP, is a tryptamine that is structurally related to N-methyltryptamine and the psychedelic drugs N,''N-dimethyltryptamine and N'',N-diethyltryptamine.

Use and effects

Alexander Shulgin included NET as an entry in his book TiHKAL. However, he stated that it had been subjected only to modest human trials and that no active dose level had been identified.

Pharmacology

Pharmacodynamics

NET has been found to act as a potent serotonin 5-HT2A receptor full agonist and a selective serotonin releasing agent. It is inactive at the 5-HT1A receptor.

Chemistry

Synthesis

The chemical synthesis of NET has been described.

Analogues

Analogues of NET include N-methyltryptamine, dimethyltryptamine, methylethyltryptamine, and diethyltryptamine, among others.

Society and culture

Legal status

Canada

NET is not a controlled substance in Canada as of 2025.